DiscoverESICM TalkLandiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial
Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial

Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial

Update: 2024-10-16
Share

Description

Autonomic dysfunction and tachycardia are strongly linked to poor outcomes in septic shock, contributing to high mortality rates. In the upcoming podcast, we explore whether β-blockade with landiolol for up to 14 days can reduce organ failure, as measured by the Sequential Organ Failure Assessment (SOFA) score, in critically ill patients with tachycardia and septic shock who have been on high-dose norepinephrine for over 24 hours.

Dr. Tony Whitehouse, interviewed by two NEXT representatives, discusses the key findings of the STRESS-L Randomized Clinical Trial.

Comments 
loading
In Channel
N&AHP – ICU diaries

N&AHP – ICU diaries

2024-05-2220:57

loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial

Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial

ESICM